SMS Lifesciences India Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
HALEOSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The promoter and promoter group of SMS Lifesciences India Limited have confirmed they have not created any encumbrance (pledge or similar charge) on their equity shares during the financial year ended March 31, 2025. The shareholding table for all 15 promoter and promoter group members shows the 'equity shares pledged' column as zero across the board, meaning no promoter shares are currently encumbered. This is a routine annual filing required under SEBI takeover regulations, not a new event.
This is a neutral, routine disclosure. Shareholders can take comfort that no promoter shares are pledged, which removes one common risk factor. No material impact on the stock price is expected.